Apoe genotypes and brain imaging classes in normal cognition, mild cognitive impairment, and alzheimer’s disease: A longitudinal study

Autor: Rosolino Camarda, Carmela Pipia, Gianluca Sottile, Giovanna Cilluffo, Cecilia Camarda, Paola Torelli
Přispěvatelé: Camarda C., Torelli P., Pipia C., Sottile G., Cilluffo G., Camarda R.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
Apolipoprotein E
medicine.medical_specialty
Genotype
Apolipoprotein E4
Neuroimaging
Neuropsychological Tests
APOE genotypes
Brain imaging classes
Caudate atrophy
Global cerebral atrophy
Lacunes
White matter hyperintensities
Aged
Aged
80 and over
Alzheimer Disease
Apolipoprotein E4
Apolipoproteins E
Brain
Case-Control Studies
Cognitive Dysfunction
Disease Progression
Female
Genotype
Humans
Longitudinal Studies
Magnetic Resonance Imaging
Male
Middle Aged
Neuroimaging
Neuropsychological Tests
Risk Factors

brain imaging classes
Apolipoproteins E
Atrophy
Alzheimer Disease
Risk Factors
Internal medicine
Global brain atrophy
medicine
Humans
Dementia
Cognitive Dysfunction
Longitudinal Studies
caudate atrophy
Aged
global cerebral atrophy
Aged
80 and over

APOE genotypes
business.industry
Neuropsychology
Brain
Middle Aged
white matter hyperintensities
medicine.disease
Magnetic Resonance Imaging
Hyperintensity
Neurology
Case-Control Studies
Disease Progression
Cardiology
Female
Neurology (clinical)
Alzheimer's disease
business
Zdroj: Current Alzheimer research
(2020). doi:10.2174/1567205017666201109093314
info:cnr-pdr/source/autori:Cecilia Camarda; Paola Torelli ;Carmela Pipia ;Gianluca Sottile ; Giovanna Cilluffo ;Rosolino Camarda/titolo:APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: a Longitudinal Study/doi:10.2174%2F1567205017666201109093314/rivista:Current Alzheimer research (Print)/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume
DOI: 10.2174/1567205017666201109093314
Popis: Objective: To evaluate in 419 stroke-free cognitively normal subjects (CN) aged 45-82 years covering during a long prospective study (11.54 ± 1.47 years) the preclinical to dementia spectrum: 1) the distribution of small vessel disease (V) and brain atrophy (A) aggregated as following: V−/A−, V−/A+, V+/A−, V+/A+; 2) the relationship of these imaging classes with individual apolipoprotein E (APOE) genotypes; 3) the risk of progression to Alzheimer Disease (AD) of the individual APOE genotypes. Methods: Participants underwent one baseline (t0), and 4 clinical and neuropsychological assessments (t1,t2,t3, and t4). Brain MRI was performed in all subjects at t0, t2, t3 and t4.. White matter hyperintensities were assessed through two visual rating scales. Lacunes were also rated. Subcortical and global brain atrophy were determined through the bicaudate ratio and the lateral ventricle to brain ratio, respectively. APOE genotypes were determined at t0 in all subjects. Cox proportional hazard model was used to evaluate the risk of progression to AD. Results: The imaging class of mixed type was very common in AD, and in non amnestic mild cognitive impaired APOE ε4 non carriers. In these subjects, frontal and parieto-occipital regions were most affected by small vessel disease. Conclusion: Our findings suggest that the APOE ε3 allele is probably linked to the brain vascular pathology.
Databáze: OpenAIRE